Recombinant Human NOV/CCN3, CF

• Supplier: R&D Systems
• Catalog: 1640-NV-050
• Category: Protein
• Nature: Recombinant
• Source: Mouse myeloma cell line, NS0-derived, Thr32-Met357, with a C-terminal 10-His tag
• Purity: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.
• SwissProt/Accession: P48745
• Gene: NOV

Product References

Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR - Nephroblastoma overexpressed (NOV/CCN3) gene: a paired-domain-specific PAX3-FKHR

Zhang Y, Wang C. Oncogene. 2011 Aug 11;30(32):3549-62.

A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and - A novel, dual role of CCN3 in experimental glomerulonephritis: pro-angiogenic and

van Roeyen CR, Boor P, Borkham-Kamphorst E, Rong S, Kunter U, Martin IV, Kaitovic A, Fleckenstein S, Perbal B, Trautwein C, Weiskirchen R, Ostendorf T, Floege J. Am J Pathol. 2012 May;180(5):1979-90.

CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous - CCN3 (NOV) is a negative regulator of CCN2 (CTGF) and a novel endogenous

Riser BL, Najmabadi F, Perbal B, Peterson DR, Rambow JA, Riser ML, Sukowski E, Yeger H, Riser SC. Am J Pathol. 2009 May;174(5):1725-34.

Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization. - Matricellular protein CCN3 (NOV) regulates actin cytoskeleton reorganization.

Sin WC, Tse M, Planque N, Perbal B, Lampe PD, Naus CC. J Biol Chem. 2009 Oct 23;284(43):29935-44.